ORKA
ORKA
US6876041087
Oruka Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
5.44B EUR
5.81B EUR
2.46B EUR
1.48B EUR
Enterprise Value
4.25B EUR
5.55B EUR
2.41B EUR
1.43B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-28.69x
--
--
--
Price to Sales
--
--
--
--
Price to Book
4.51x
5.23x
5.09x
3.15x
EV/Revenue
--
--
--
--
EV/EBITDA
-27.42x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-1.2%
-1.74%
-3.71%
-4.57%
ende